Serum Cytokine Biomarkers for Use in Diagnosing Pulmonary Tuberculosis versus Chronic Pulmonary Aspergillosis

References

• World Health Organization. Global Tuberculosis Report 2022. World Health Organization; 2022.
   Google Scholar
• MacLean E, Kohli M, Weber SF, et al. Advances in molecular diagnosis of tuberculosis. J Clin Microbiol. 2020;58(10). doi:10.1128/JCM.01582-19
   PubMed Web of Science ®Google Scholar
• Wang L, Zhang H, Ruan Y, et al. Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data. Lancet. 2014;383(9934):2057–2064. doi:10.1016/S0140-6736(13)62639-2
   PubMed Web of Science ®Google Scholar
• Kosmidis C, Denning DW. The clinical spectrum of pulmonary aspergillosis. Thorax. 2015;70(3):270–277. doi:10.1136/thoraxjnl-2014-206291
   PubMed Web of Science ®Google Scholar
• Page ID, Byanyima R, Hosmane S, et al. Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation. Eur Respir J. 2019;53(3). doi:10.1183/13993003.01184-2018
   PubMedGoogle Scholar
• Denning DW, Pleuvry A, Cole DC. Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis. Bull World Health Organ. 2011;89(12):864–872. doi:10.2471/BLT.11.089441
   PubMed Web of Science ®Google Scholar
• Ohba H, Miwa S, Shirai M, et al. Clinical characteristics and prognosis of chronic pulmonary aspergillosis. Respir Med. 2012;106(5):724–729. doi:10.1016/j.rmed.2012.01.014
   PubMedGoogle Scholar
• Lowes D, Al-Shair K, Newton PJ, et al. Predictors of mortality in chronic pulmonary aspergillosis. Eur Respir J. 2017;49(2). doi:10.1183/13993003.01062-2016
   PubMedGoogle Scholar
• Al-Shair K, Atherton GT, Harris C, Ratcliffe L, Newton PJ, Denning DW. Long-term antifungal treatment improves health status in patients with chronic pulmonary aspergillosis: a longitudinal analysis. Clin Infect Dis. 2013;57(6):828–835. doi:10.1093/cid/cit411
   PubMed Web of Science ®Google Scholar
• Camuset J, Nunes H, Dombret MC, et al. Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients. Chest. 2007;131(5):1435–1441. doi:10.1378/chest.06-2441
   PubMed Web of Science ®Google Scholar
• Zou M, Tang L, Zhao S, et al. Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis. PLoS One. 2012;7(8):e43347. doi:10.1371/journal.pone.0043347
   PubMed Web of Science ®Google Scholar
• Ma X, Wang K, Zhao X, et al. Prospective study of the serum Aspergillus-specific IgG, IgA and IgM assays for chronic pulmonary aspergillosis diagnosis. BMC Infect Dis. 2019;19(1):694. doi:10.1186/s12879-019-4303-x
   PubMedGoogle Scholar
• Salzer HJF, Massango I, Bhatt N, et al. Seroprevalence of Aspergillus-specific IgG antibody among Mozambican tuberculosis patients. J Fungi. 2021;7(8):595. doi:10.3390/jof7080595
   Google Scholar
• Lee MR, Huang HL, Chen LC, et al. Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study. Clin Microbiol Infect. 2020;26(8):1091.e1–1091.e7. doi:10.1016/j.cmi.2019.12.009
   Google Scholar
• Allard JB, Poynter ME, Marr KA, Cohn L, Rincon M, Whittaker LA. Aspergillus fumigatus generates an enhanced Th2-biased immune response in mice with defective cystic fibrosis transmembrane conductance regulator. J Immunol. 2006;177(8):5186–5194. doi:10.4049/jimmunol.177.8.5186
   PubMedGoogle Scholar
• Cramer RA, Rivera A, Hohl TM. Immune responses against Aspergillus fumigatus: what have we learned? Curr Opin Infect Dis. 2011;24(4):315–322. doi:10.1097/QCO.0b013e328348b159
   PubMed Web of Science ®Google Scholar
• Bozza S, Clavaud C, Giovannini G, et al. Immune sensing of Aspergillus fumigatus proteins, glycolipids, and polysaccharides and the impact on Th immunity and vaccination. J Immunol. 2009;183(4):2407–2414. doi:10.4049/jimmunol.0900961
   PubMed Web of Science ®Google Scholar
• Wéry N. Bioaerosols from composting facilities--a review. Front Cell Infect Microbiol. 2014;4:42. doi:10.3389/fcimb.2014.00042
   PubMed Web of Science ®Google Scholar
• Denning DW, Park S, Lass-Florl C, et al. High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis. 2011;52(9):1123–1129. doi:10.1093/cid/cir179
   PubMed Web of Science ®Google Scholar
• Patterson TF, Thompson GR 3rd, Denning DW, et al. Practice guidelines for the diagnosis and management of Aspergillosis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;63(4):e1–e60. doi:10.1093/cid/ciw326
   PubMed Web of Science ®Google Scholar
• Denning DW, Cadranel J, Beigelman-Aubry C, et al. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J. 2016;47(1):45–68. doi:10.1183/13993003.00583-2015
   PubMed Web of Science ®Google Scholar
• Rhodes JC. Aspergillus fumigatus: growth and virulence. Med Mycol. 2006;44(Suppl 1):S77–S81. doi:10.1080/13693780600779419
   PubMed Web of Science ®Google Scholar
• Hayes GE, Novak-Frazer L. Chronic pulmonary Aspergillosis-where are we? And where are we going? J Fungi. 2016;2(2):18. doi:10.3390/jof2020018
   Google Scholar
• Asner SA, Science ME, Tran D, Smieja M, Merglen A, Mertz D. Clinical disease severity of respiratory viral co-infection versus single viral infection: a systematic review and meta-analysis. PLoS One. 2014;9(6):e99392. doi:10.1371/journal.pone.0099392
   PubMed Web of Science ®Google Scholar
• Nongrum S, Singh VA, Paul R, Karnik S, Mehta S, Bera SS. A study about co-infection of fungal pathogens in active tuberculosis patients. Mymensingh Med J. 2019;28(4):920–924.
   PubMedGoogle Scholar
• Yan ZH, Yi L, Wei PJ, et al. Evaluation of panels of Mycobacterium tuberculosis antigens for serodiagnosis of tuberculosis. Int J Tuberc Lung Dis. 2018;22(8):959–965. doi:10.5588/ijtld.18.0060
   PubMedGoogle Scholar
• Baumann R, Kaempfer S, Chegou NN, et al. Serologic diagnosis of tuberculosis by combining Ig classes against selected mycobacterial targets. J Infect. 2014;69(6):581–589. doi:10.1016/j.jinf.2014.05.014
   PubMedGoogle Scholar
• Bai XJ, Yang YR, Liang JQ, et al. Diagnostic performance and problem analysis of commercial tuberculosis antibody detection kits in China. Mil Med Res. 2018;5(1):10. doi:10.1186/s40779-018-0157-6
   PubMedGoogle Scholar
• Patel G, Greenberger PA. Allergic bronchopulmonary aspergillosis. Allergy Asthma Proc. 2019;40(6):421–424. doi:10.2500/aap.2019.40.4262
   PubMedGoogle Scholar
• Liu Y, Li Z, Wang S, et al. Aspergillus fumigatus induces the release of IL-8 and MCP-1 by activating nuclear transcription through dectin-1 and CR3 receptors in alveolar epithelial cells. Curr Microbiol. 2021;78(9):3474–3482. doi:10.1007/s00284-021-02534-5
   PubMedGoogle Scholar
• Croft CA, Culibrk L, Moore MM, Tebbutt SJ. Interactions of Aspergillus fumigatus conidia with airway epithelial cells: a critical review. Front Microbiol. 2016;7:472. doi:10.3389/fmicb.2016.00472
   PubMed Web of Science ®Google Scholar
• Øya E, Solhaug A, Bølling AK, et al. Pro-inflammatory responses induced by A. fumigatus and A. versicolor in various human macrophage models. J Toxicol Environ Health A. 2019;82(8):483–501. doi:10.1080/15287394.2019.1619114
   PubMed Web of Science ®Google Scholar
• Sales-Campos H, Tonani L, Cardoso CR, Kress MR. The immune interplay between the host and the pathogen in Aspergillus fumigatus lung infection. Biomed Res Int. 2013;2013:693023. doi:10.1155/2013/693023
   PubMed Web of Science ®Google Scholar
• Abebe F. Synergy between Th1 and Th2 responses during Mycobacterium tuberculosis infection: a review of current understanding. Int Rev Immunol. 2019;38(4):172–179. doi:10.1080/08830185.2019.1632842
   PubMedGoogle Scholar
• Salzer HJF, Prattes J, Flick H, et al. Evaluation of galactomannan testing, the Aspergillus-specific lateral-flow device test and levels of cytokines in bronchoalveolar lavage fluid for diagnosis of chronic pulmonary Aspergillosis. Front Microbiol. 2018;9:2223. doi:10.3389/fmicb.2018.02223
   PubMed Web of Science ®Google Scholar
• Krupa A, Fol M, Dziadek BR, et al. Binding of CXCL8/IL-8 to Mycobacterium tuberculosis modulates the innate immune response. Mediators Inflamm. 2015;2015:124762. doi:10.1155/2015/124762
   PubMedGoogle Scholar